A
Anthony R. Dal Nogare
Researcher at University of Texas Southwestern Medical Center
Publications - 13
Citations - 1566
Anthony R. Dal Nogare is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Septic shock & Shock (circulatory). The author has an hindex of 11, co-authored 13 publications receiving 1530 citations. Previous affiliations of Anthony R. Dal Nogare include University Medical Center New Orleans.
Papers
More filters
Journal ArticleDOI
Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock
Edward Abraham,Antonio Anzueto,Guillermo Gutierrez,Sidney Tessler,Gerry San Pedro,Richard G. Wunderink,Anthony R. Dal Nogare,Stanley A. Nasraway,Steve Berman,Robert N. Cooney,Howard Levy,Robert P. Baughman,Mark J. Rumbak,R. Bruce Light,Lona Poole,Randy Allred,John Constant,James E Pennington,Steven B. Porter +18 more
TL;DR: It was found there was no association between therapy with TNFα MAb and increased rapidity in reversal of initial shock or prevention of subsequent shock, and baseline plasma interleukin-6 concentrations were not associated with improvement in survival after TNF α MAb therapy.
Journal ArticleDOI
A Randomized Trial of Empyema Therapy
TL;DR: In patients with loculated, complex fibrinopurulent parapneumonic empyema thoracis, a primary treatment strategy of VATS is associated with a higher efficacy, shorter hospital duration, and less cost than a treatment strategy that utilizes catheter-directed fibrinolytic therapy.
Journal ArticleDOI
Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study.
Edward Abraham,Konrad Reinhart,Petr Svoboda,Allan Seibert,Derk Olthoff,Anthony R. Dal Nogare,Russell Postier,Gunter Hempelmann,Thomas Butler,Eike Martin,Christian Zwingelstein,Sandra Percell,Vincent Shu,Anton Leighton,Abla A. Creasey +14 more
TL;DR: This study demonstrates that rTFPI doses of 0.025 and 0.05 mg/kg/hr could be safely administered to severe sepsis patients and biological activity, as detected by a statistically significant reduction in thrombin-antithrombin complexes and interleukin-6 levels, was noted in the all rT FPI-treated patients compared with those receiving placebo.
Journal ArticleDOI
Southwestern Internal Medicine Conference: Septic Shock
TL;DR: Septic shock is the most common type of shock encountered by internists, and its prevalence appears to be increasing.
Journal ArticleDOI
Relationship between diabetes control and pulmonary function in insulin-dependent diabetes mellitus.
Luis C. Ramirez,Anthony R. Dal Nogare,Connie C.W. Hsia,Carlos Arauz,Irfan Butt,Suzanne M. Strowig,Laura Schnurr-Breen,Philip Raskin +7 more
TL;DR: These data confirm previous reports of abnormal respiratory function in subjects with insulin-dependent diabetes mellitus and suggest that long-term near-normoglycemia may be beneficial in preventing the deterioration of pulmonary function associated with Diabetes mellitus.